XML 321 R111.htm IDEA: XBRL DOCUMENT v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
6 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2025
Cash Flows from Operating Activities:    
Net income   $ (21,780,225)
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest earned on marketable securities held in Trust Account   (169,416)
Changes in operating assets and liabilities:    
Net cash used in operating activities   (10,828,412)
Cash Flows from Investing Activities:    
Net cash used in investing activities   (1,029,332)
Cash Flows from Financing Activities:    
Net cash provided by financing activities   36,668,939
Cash and cash equivalents at beginning of period   3,021,795
Cash and cash equivalents at end of period $ 2,014,357 27,739,256
HCM II ACQUISITION CORP    
Cash Flows from Operating Activities:    
Net income 1,018,558 3,218,865
Adjustments to reconcile net loss to net cash used in operating activities:    
Formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares 12,463
Formation and operational costs paid through promissory note - related party 45,200
Interest earned on marketable securities held in Trust Account (1,349,715) (7,449,387)
Initial loss on forward purchase agreement liability 893,425
Change in fair value of forward purchase agreement liability (893,425)
Changes in operating assets and liabilities:    
Other receivable (41,250) 41,250
Prepaid expenses (60,869) (15,482)
Short-term prepaid insurance (90,250) 15,042
Long-term prepaid insurance (75,208) 52,646
Accrued expenses 246,941 3,081,364
Net cash used in operating activities (294,130) (1,055,702)
Cash Flows from Investing Activities:    
Investment of cash into Trust Account (231,150,000)
Net cash used in investing activities (231,150,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts paid 226,000,000
Proceeds from sale of Private Placements Warrants 6,850,000
Convertible notes advance received 338,002
Proceeds from promissory note - related party 400,000
Repayment of promissory note - related party (233,127)
Payment of offering costs (347,609)
Net cash provided by financing activities 232,269,264 738,002
Net Change in Cash 825,134 (317,700)
Cash and cash equivalents at beginning of period 668,089
Cash and cash equivalents at end of period 825,134 350,389
Non-Cash investing and financing activities:    
Accrued offering costs 127,941
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares 12,537
Deferred offering costs paid through promissory note - related party 187,927
Deferred underwriting fee payable $ 10,720,000